Association of Prolonged Disease Duration and TG/HDL-C Ratio in Accelerating Atherosclerosis in Patients with Takayasu's Arteritis
暂无分享,去创建一个
Yaxin Zhang | Shiyu Yang | Jiayi Liu | L. Pan | Yanlong Ren | Juan Du | Taotao Li | Xi Guo | Wen-Xian Liu | Liying Chen | Tie-duo Kang | Shangqiu Ning
[1] P. Nienhuis,et al. A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis , 2021, Journal of personalized medicine.
[2] Qingbo Xu,et al. Trajectories of Age-Related Arterial Stiffness in Chinese Men and Women. , 2020, Journal of the American College of Cardiology.
[3] Rachel M. Kenney,et al. Sex differences in mechanisms of arterial stiffness , 2019, British journal of pharmacology.
[4] Shouling Wu,et al. Higher triglyceride to high‐density lipoprotein cholesterol ratio increases cardiovascular risk: 10‐year prospective study in a cohort of Chinese adults , 2019, Journal of diabetes investigation.
[5] C. Turesson,et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis , 2019, Annals of the rheumatic diseases.
[6] M. Hemmati,et al. Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran , 2018, Clinical Medicine Insights. Cardiology.
[7] P. Sfikakis,et al. Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives , 2018, Current opinion in rheumatology.
[8] Y. Yılmaz,et al. Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease? , 2016, Northern clinics of Istanbul.
[9] S. Heymans,et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. , 2015, International journal of cardiology.
[10] Dinesh Kumar,et al. NMR-Based Serum Metabolomics Discriminates Takayasu Arteritis from Healthy Individuals: A Proof-of-Principle Study. , 2015, Journal of proteome research.
[11] Yucheng Chen,et al. The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization , 2015, PloS one.
[12] J. Francis,et al. Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges , 2015, Journal of Cardiovascular Magnetic Resonance.
[13] J. Grau,et al. Evaluation of Aortic Inflammation Using Computed Tomographic Angiography: Vasculitis, Atherosclerosis, or Both , 2015, Journal of the American Geriatrics Society.
[14] A. Dang,et al. Association of abnormal lipid spectrum with the disease activity of Takayasu arteritis , 2015, Clinical Rheumatology.
[15] H. Direskeneli,et al. Impaired endothelial function in patients with Takayasu’s arteritis , 2014, Acta cardiologica.
[16] Rajiva Gupta,et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). , 2013, Rheumatology.
[17] S. Yurdakul,et al. Aortic and coronary calcifications in Takayasu arteritis. , 2013, Seminars in arthritis and rheumatism.
[18] S. Gabriel,et al. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE , 2011, Nature Reviews Rheumatology.
[19] D. Symmons,et al. Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis? , 2011, Angiology.
[20] B. Dijkmans,et al. The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better , 2010, International journal of clinical practice.
[21] S. Juo,et al. The risk of the metabolic syndrome on carotid thickness and stiffness: sex and age specific effects. , 2010, Atherosclerosis.
[22] D. Symmons,et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.
[23] R. Pereira,et al. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis , 2009, Clinical Rheumatology.
[24] S. Heo,et al. Takayasu’s disease presenting with atherothrombotic ischaemic stroke , 2008, Neurological Sciences.
[25] W. Mack,et al. Carotid artery intima-media thickness after raloxifene treatment. , 2007, Journal of women's health.
[26] F. Dockery,et al. Takayasu's arteritis: a cause of prolonged arterial stiffness. , 2006, Rheumatology.
[27] N. Seyahi,et al. Atherosclerosis in Takayasu arteritis , 2006, Annals of the rheumatic diseases.
[28] H. Hashimoto,et al. Menopause is an independent factor augmenting the age-related increase in arterial stiffness in the early postmenopausal phase. , 2006, Atherosclerosis.
[29] K. G. Rajesh,et al. Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. , 2003, American journal of physiology. Heart and circulatory physiology.
[30] T. Kakuta,et al. Inflammation and Atherosclerosis: Atherosclerotic Lesions in Takayasu Arteritis , 2000, Annals of the New York Academy of Sciences.
[31] F. Numano,et al. Angiographic findings of Takayasu arteritis: new classification. , 1996, International journal of cardiology.
[32] Guy Hoffman,et al. Takayasu Arteritis , 1994, Annals of Internal Medicine.
[33] G. Hunder,et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. , 2010, Arthritis and rheumatism.
[34] M. Srichai,et al. Takayasu's Arteritis , 2012 .